The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
Local services also consider the approach to improve referral processes for community nursing services and support better outcomes and experience for care home residents. Consequently, local partners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback